Sacral nerve stimulation in patients with ileal pouch-anal anastomosis

J-pouch formation with ileal pouch-anal anastomosis (IPAA) is the restorative procedure of choice after proctocolectomy [1]. Functional results after IPAA are usually very good [2‐4]. However, fecal incontinence may be a consequence and negatively impact quality of life (QoL) and overall outcome. Fecal incontinence is defined as the inability to control feces or gas. The range of fecal incontinence described after IPAA varies widely and seems to progress over time [3‐5]. Daytime stool incontinence is described in 1 to 25% of patients after J-pouch formation with IPAA [2‐7]. Incontinence at night seems to be more common at 8 to 49% [3‐8]. Increased stool frequency is another reported factor that negatively impacts quality of life [9].

The pathogenesis of fecal incontinence after J-pouch reconstruction with IPAA is not fully understood. On the one hand, proctocolectomy with IPAA includes thorough intersphincteric excision and, on the other hand, maximum preservation of the sphincter function. Even so, the procedure can affect the upper parts of the internal sphincter and therefore may cause dysfunction, mainly at night [8]. Another possible mechanism could be a delayed function of the puborectalis muscle due to an altered postoperative latency of the sacral nerve [10].

Sacral nerve stimulation (SNS) is an established therapy for fecal incontinence in general or in patients with sphincter defects [11, 12] with low perioperative morbidity and good patients’ experience [12, 13]. Recent experience has shown good feasibility and clinical benefit, albeit based primarily on retrospective data [14, 15]. In addition, SNS seems to be also effective in the treatment of functional deficits after IPAA [2, 16]. These observations are encouraging but are based on studies with a small number of patients [2]. There is a case report (n = 1) [17], a retrospective study (n = 7) [18], and a cohort study (n = 4) [16] working on SNS for IPAA. We, therefore, analyzed our experience from over 20 years of IPAA surgery and SNS. With this study, we aimed to evaluate the effectiveness and usefulness of SNS therapy for the treatment of fecal incontinence according to IPAA.

The indication for SNS implantation in patients with refractory fecal incontinence treatment after IPAA was based on individual decisions and is currently not an established therapeutic method, including in this work. All selected patients initially received a PNE (percutaneous nerve examination) as part of a test phase. Since all patients showed a positive signal to PNE, a temporary stimulating electrode was placed under general anesthesia. Based on clinical standards, prophylactic antibiotics were given prior to the procedure. During electrode insertion, radiological controls of correct placement close to sacral foramen two (S2) or three (S3) and electrophysiological monitoring of contractions of the pelvic floor, the external anal sphincter, and the toe were performed. Optimal electrode position was defined as the best motor response of the pelvic floor/external sphincter muscle with low stimulation amplitude. The PNE line then was attached to the skin. PNE was started 4 to 12 h after intervention. After hospital discharge and with a successful response and symptom improvement of at least 50%, the final SNS was implanted. If improvement was less than 50%, PNE were removed. For final implantation, a tined quadripolar lead was inserted into the same sacral foramen and evaluated under radiological and electrophysiological monitoring as with the PNE. The electrode was then leaded subcutaneously and connected with an implantable pulse generator (IPG, Medtronic, Interstim 3625) according to the manufacturer’s recommendations. The IPG was implanted and fixed subcutaneously in the gluteal area, and the wound was closed in two-layer suture. Stimulation was started 12 h after intervention with a program configuration according to patient’s sensory response. Wound scaring, local pain, and therapy success were controlled 2 and 6 weeks after the procedure.

Since most variables showed skewed distributions, non-parametric tests were used for statistical comparison. Continuous variables are displayed as median (minimum–maximum), and categorical variables are displayed as count (percentage). ASA is displayed as mean (minimum–maximum) to allow for a finer graduation. The Mann–Whitney U test was used to compare two independent groups. For dependent variables, the Wilcoxon test was used. The chi-square test was used for group comparisons of categorical variables. The level of significance was 0.05 (two-sided) for each statistical testing. The statistical analysis was performed with SPSS Statistics Software 25.0 (IBM, Armonk, NY, USA).

The Medical Ethical Committee of Charité — Universitätsmedizin Berlin (EA1/289/20) approved the study protocol.

The aim of our study was to evaluate the feasibility and the benefit of sacral nerve stimulation (SNS) in the treatment of fecal incontinence in patients with J-pouch reconstruction and ileal pouch-anal anastomosis (IPAA).

Our study shows the feasibility of SNS in IPAA patients by improving fecal incontinence (as measured by the St. Marks incontinence score) in more than two-thirds of patients with fecal incontinence or high stool frequency. The St. Marks incontinence or Vaizey score was used as a rating system for the assessment of the severity of fecal incontinence [19]. Our results showed a significant improvement after SNS implantation from 19 to 4 in the St. Marks incontinence score. There is some evidence that shows a positive correlation between St. Marks incontinence score and quality of life [20, 21]. With decreasing severity of the St. Marks incontinence score, the quality of life measured with the Manchester Health Questionnaire (MHQ) was improved [21]. Due to this positive correlation, indirect conclusions can also be drawn about a better quality of life observed in our patient cohort after successful SNS implantation. In our study, we were able to demonstrate an improvement in nighttime incontinence after SNS. Although some data were missing for the evaluation, this may indicate a possible improvement in quality of life after SNS for these patients.

In the analysis of possible factors influencing the success of SNS, a significantly higher BMI of 30.2 kg/m² (24.9–38.9) was found for non-successful SNS. However, the statistical significance of BMI on success after SNS must be taken with caution in view of the missing data. The data lack is mainly due to the conversion of the patient recording system from analog to digital over the years. However, it is consistent with the literature that there are more perioperative problems with IPAA in obese patients [22, 23].

Increased stool frequency is another reported factor that negatively impacts quality of life [9]. However, overall stool frequency was not affected by SNS implantation in this analysis. This is reflected in previous work describing low daytime fecal incontinence of 1 to 25% in contrast to nighttime incontinence of 8 to 49% [2‐8].

In seven patients, the therapy had to be discontinued after the test phase and the electrodes removed because the SNS implantation was not successful. In some of these patients, a new stoma or even a pouch explantation had to be performed. Postoperative pouchitis or fistulas could be a cause of reduced pouch function. As described in the literature, chronic pouchitis, fistulas, leakage, or conversion to a diagnosis of Crohn’s disease pose a clear risk for failure of the J-pouch and IPAA [24, 25]. However, some patients had persistent incontinence for no apparent reason. Further investigations seem necessary to clarify the causes of SNS failure.

A limitation of this study was the partially incomplete data collection. On the one hand, this is due to the very long study period of 20 years with a certain loss of data due to the conversion of the documentation from analog to digital. On the other hand, the follow-up data are missing because they were either collected in the patients’ hometowns or not at all. A retrospective survey might have yielded more results. Our results on stool frequency and nocturnal incontinence must therefore be interpreted cautiously, as the number of missing values was quite high.

However, the strength of our work lies in the relatively large number of patients and the long follow-up period with an average of 6 years. As there are only single case reports and small studies in the literature so far, it is now possible to make more comprehensive statements about the success of SNS use for fecal incontinence after IPAA.

SNS implantation for the treatment of fecal incontinence and high stool frequency in patients with J-pouch and ulcerative colitis shows good results. SNS appears to be a good therapy option for these patients and should be considered at an early stage and may offer an alternative to J-pouch removement or permanent stoma application.